Researchers develop peptide that can target tumors, deliver agents

10/27/2009 | EurekAlert!

Two University of Rhode Island researchers have developed a peptide called pHLIP that was able to locate a tumor in a mouse then deliver imaging and therapeutic agents to the cancer cells without harming surrounding healthy cells. The peptide's delivery method involves the use of a molecular nanosyringe that can deliver nanogold particles directly to the cancerous tumors. The technology has a pending patent in the U.S. and Europe.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA